Aprea Therapeutics Insider Trades

APRE

Track insider trading activity from Aprea Therapeutics executives and directors. See which insiders are buying and selling APRE stock.

Trades Last 12 Months

All Insider Trades for Aprea Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Gruia Gabriela Director
Holding Value $9.15k 12,555 shares
Last Trade
Jun 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.5k 15,690 shares
$0.73
$0.73
Pamukcu Rifat Director
Holding Value $9.15k 12,555 shares
Last Trade
Jun 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.5k 15,690 shares
$0.73
$0.73
Peters Richard Director
Holding Value $9.15k 12,555 shares
Last Trade
Jun 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.5k 15,690 shares
$0.73
$0.73
Holding Value $35.6k 48,910 shares
Last Trade
Jun 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.5k 15,690 shares
$0.73
$0.73
Holding Value $9.15k 12,555 shares
Last Trade
Jun 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.5k 15,690 shares
$0.73
$0.73
Holding Value $9.73k 13,364 shares
Last Trade
Jun 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.5k 15,690 shares
$0.73
$0.73
Duey Marc Director
Holding Value $189k 259,290 shares
Last Trade
Jun 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.5k 15,690 shares
$0.73
$0.73
Holding Value $9.15k 12,555 shares
Last Trade
Jun 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.5k 15,690 shares
$0.73
$0.73
Hamill John P. Srvp/cfo/prin Fin & Acct Ofcr
Holding Value $22.6k 30,978 shares
Last Trade
Mar 31, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$47.3k 61,956 shares
$0.76
$0.73
Gilad Oren President/ceo
Holding Value $287k 393,895 shares
Last Trade
Mar 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$77.2k 100,875 shares
$0.76
$0.73
Holding Value $3.05k 4,185 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.57k 4,185 shares
$1.81
$0.73
Holding Value $7.45k 10,229 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.57k 4,185 shares
$1.81
$0.73
Mirza Nadeem Q. Chief Medical Officer
Holding Value $19.6k 26,920 shares
Last Trade
May 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$141k 26,920 shares
$5.25
$0.73
Korbel Gregory Alan Svp, Chief Operating Officer
Holding Value $33.3k 45,762 shares
Last Trade
Jul 28, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.31M 60,000 shares
$21.80
$0.73
Coiante Scott M Svp, Chief Financial Officer
Holding Value $106k 145,065 shares
Last Trade
Jul 28, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.27M 150,000 shares
$21.80
$0.73
Holding Value $189k 259,246 shares
Last Trade
Jul 28, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$706k 32,400 shares
$21.80
$0.73
Abrahmsen Lars B. Svp, Chief Scientific Officer
Holding Value $72.8k 100,000 shares
Last Trade
Mar 10, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.54M 124,700 shares
$36.40
$0.73
Namouni Fouad Director
Holding Value $16.6k 22,750 shares
Last Trade
Jun 30, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.67M 27,360 shares
$97.60
$0.73
Holding Value $3.36k 4,610 shares
Last Trade
Jun 30, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.22M 22,750 shares
$97.60
$0.73
Attar Eyal C. Svp, Chief Medical Officer
Holding Value $24k 33,000 shares
Last Trade
Feb 25, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.2M 143,000 shares
$120.00
$0.73

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up